Treatment Interval Progression and Adherence to Observe-and-Plan Regimen for Neovascular Age-Related Macular Degeneration Treated with Aflibercept 2 mg
Aflibercept 2 mg in an O&P treatment regimen leads to a variety of treatment intervals, and some eyes may be overtreated. An important proportion of eyes deviate from the intended O&P treatment regimen. Our study contributes to understanding real-world implications of personalized treatment regimens.
Authors
- Oliver Niels Klefter (ORCID: https://orcid.org/0000-0003-2313-5648)
- Yousif Subhi (ORCID: https://orcid.org/0000-0001-6620-5365)
- Delila Hodzic‐Hadzibegovic (ORCID: https://orcid.org/0000-0001-5971-2713)
- Javad Nouri Hajari (ORCID: https://orcid.org/0000-0001-5336-8253)
- Miklós Schneider (ORCID: https://orcid.org/0000-0003-1488-4743)
- Morten la Cour (ORCID: https://orcid.org/0000-0002-7712-9772)
- Andreas Arnold‐Vangsted
- Leyla Turan
Institutions
- Semmelweis University (HU)
- University of Copenhagen (DK)
- University of Southern Denmark (DK)
- Glostrup Hospital (DK)
- Rigshospitalet (DK)
- IT University of Copenhagen (DK)
Publication Details
- Journal
- Ophthalmology and Therapy
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1007/s40123-025-01095-1
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71